Onconetix Faces Compliance Challenges Affecting Nasdaq Index Fund Eligibility

2 min read | May 23, 2025 02:46 PM PDT | By Team Kalkine Media

Google News:

Onconetix Faces Compliance Challenges Affecting Nasdaq Index Fund Eligibility — Image source: Shutterstock

Recent News

Cigna Adjusts Coverage Decisions Across Its Health Operations

Steel Dynamics Draws Attention With Record Shipments

Southern Company Serves A Data Center Hotspot

Vistra Sits In The Path Of Rising Electricity Demand

Make Kalkine Media
My Trusted Source

Highlights

Onconetix received multiple delisting notices from Nasdaq for non-compliance.

The company’s shares trade on Nasdaq and OTC markets under the ticker ONCO.

A hearing is scheduled to address continued listing requirements and bid price concerns.

Onconetix, operating within the biotechnology sector, is currently listed on nasdaq index fund markets under the ticker (NASDAQ:ONCO). These exchanges maintain strict rules for continued listing, including timely filing of quarterly and annual reports and maintaining a minimum bid price. Onconetix recently received multiple notices related to failure to meet these requirements.

Details of Nasdaq Delisting

Onconetix was issued a staff delisting letter by Nasdaq citing failure to file the quarterly report for the period ended March. Additionally, the company did not file its annual report as required, resulting in a deficiency notice. Nasdaq requires companies to meet specific financial reporting and share price standards, which Onconetix did not fulfill.

Bid Price and Trading Suspension

The Nasdaq Listing Qualifications Staff issued a further notice about the company’s stock price remaining below the minimum bid price requirement for an extended period. This prompted a trading suspension threat. However, Onconetix requested a hearing and a stay of suspension, temporarily maintaining trading pending a final decision.

Regulatory Hearing and Compliance Efforts

A hearing has been scheduled to review Onconetix’s compliance status with Nasdaq listing rules. The company has expressed intentions to file the required reports promptly to regain compliance with the regulatory framework. This process will determine if the company can maintain its listing on Nasdaq and OTC markets.

Implications for Onconetix’s Public Trading Status

The ongoing review and regulatory actions reflect the company’s challenges in meeting listing standards on Nasdaq and OTC platforms. Compliance with filing deadlines and bid price rules is essential to remain on these exchanges. The scheduled hearing is a crucial step in this process.

Impact on the Biotechnology Sector

Companies within the biotechnology sector often face scrutiny regarding regulatory and financial reporting requirements. Onconetix’s (NASDAQ:ONCO) situation the importance of adherence to exchange rules to sustain public trading status and market presence.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.